Chapter 2
Fat-Soluble Vitamins

◆ Lesson 2.1 Introduction to Fat-Soluble Vitamins

Learning goal: Understand why these four vitamins are grouped as "fat-soluble" and what that property means for absorption, storage, and daily requirements.

Four vitamins—A, D, E, K—share a critical property: they dissolve in fat, not water. This single chemical fact determines how you absorb them, how your body stores them, how much you need daily, and how easy it is to overdose. A water-soluble vitamin like C passes through your system; excess is excreted in urine. A fat-soluble vitamin like A accumulates in liver and adipose tissue; excess builds up over time. One vitamin is made on your skin in sunlight (vitamin D); another is made by your gut bacteria (vitamin K). Understanding their shared property—fat-solubility—is the key to understanding their function and risk.

1Why "Fat-Soluble"?

These four vitamins are organic molecules with a hydrophobic (water-repelling) region. They do not dissolve in the aqueous environment of your intestine or bloodstream. Instead, they travel packaged in lipoproteins—fat-carrying vehicles. This means absorption requires dietary fat; toxicity is possible because they accumulate. It also means that people with fat malabsorption (celiac, Crohn's, cystic fibrosis) are at risk for deficiencies of all four, regardless of intake.

2Storage in the Body

Unlike water-soluble vitamins (which you must consume regularly), fat-soluble vitamins are stored in body fat. A well-nourished person carries reserves of vitamins A and D lasting months. Vitamin E is distributed in all cell membranes; vitamin K is stored in liver. These reserves mean you do not need fat-soluble vitamins every single day. But they also mean that excess intake accumulates, and toxicity is possible—especially with vitamins A and D from supplements.

3RDA and Dosing Strategy

Because fat-soluble vitamins are stored, RDAs are designed to build and maintain body reserves, not to cover daily loss (as with water-soluble vitamins). Vitamin A RDA is 700–900 μg per day (for adults); this covers daily needs while maintaining liver stores. Vitamin D RDA is 600–800 IU daily, though many experts argue it is too low (see Lesson 2.5). Because of storage, skipping a day of vitamin A or D is not dangerous; a week of adequate intake covers needs. But chronically exceeding the upper limit (UL) leads to toxicity.

4The Four Vitamins at a Glance

Vitamin A (retinol): Vision, immune function, gene expression. Stored in liver. Toxicity possible. Obtained from animal sources (preformed retinol) or plant sources (carotenoids, converted to retinol by your body).

Vitamin D (cholecalciferol, ergocalciferol): Calcium regulation, immune function, gene expression. Synthesized on skin in sunlight; also obtained from food. Stored in adipose tissue. Critical for bone health; deficiency is epidemic in India.

Vitamin E (tocopherols): Antioxidant, protects cell membranes. Distributed throughout fat tissues. Deficiency is rare. Toxicity from food is impossible; toxicity from supplementation is rare but possible.

Vitamin K (phylloquinone, menaquinones): Blood clotting, bone mineralization, vascular function. Made by gut bacteria and obtained from food. Deficiency is rare in adults; toxicity is very rare.

Next: Vitamin A is the most thoroughly studied fat-soluble vitamin. Its roles in vision, immunity, and gene expression are well-established, as are the consequences of deficiency. We examine its sources, metabolism, and status in India.

◆ Lesson 2.2 Vitamin A

Learning goal: Describe vitamin A's functions, sources, bioavailability, and the prevalence of deficiency in India.

Vitamin A exists in two forms in food: preformed retinol (from animal sources) and provitamin A carotenoids (from plant sources). Your body converts carotenoids to retinol as needed. Retinol is the metabolically active form; it binds to retinoid receptors in cells, turning genes on and off. Vitamin A deficiency is a leading cause of preventable blindness in children worldwide, and it is endemic in India—particularly in rural areas, among the poor, and in children. Understanding sources, bioavailability, and deficiency signs is essential for anyone working in Indian nutrition.

1Functions of Vitamin A (Retinol)

Vision: Retinol is converted to retinal in the retina of the eye, where it combines with opsin to form rhodopsin (the visual pigment). Rhodopsin is essential for dim-light vision and color vision. Deficiency impairs night vision first—a child cannot see in dim light and may avoid playing after sunset. This is an early, reversible sign of deficiency.

Immune function: Retinoid receptors are present on immune cells (T cells, B cells, dendritic cells). Vitamin A regulates immune response—too little suppresses immunity (infections increase); too much dysregulates it (autoimmune risk). This is why vitamin A supplementation in deficient populations reduces child mortality from infections by ~10–15%.

Epithelial cell function: Vitamin A is needed for normal differentiation of skin and mucous membrane cells. Deficiency leads to squamous metaplasia—replacement of normal columnar cells (which secrete mucus) with squamous cells (keratinized, dry). This affects the conjunctiva (eyes), airways, and GI tract, increasing infection risk.

Gene expression: Retinoid receptors (RARs, RXRs) bind to DNA and regulate transcription of dozens of genes involved in growth, differentiation, and metabolism.

2Food Sources in India

Preformed retinol (animal sources): Liver (very high—10,000+ μg per 100g, but rarely eaten in quantity), milk and milk products (but low fat milk has little vitamin A), eggs (moderate). For most Indians, dairy and eggs are occasional, not daily.

Carotenoids (plant sources): Orange/yellow vegetables (sweet potato, pumpkin, carrots, though carrots are expensive), leafy greens (spinach, fenugreek, amaranth leaves), orange fruits (mango, papaya). Indian diets have seasonal access to these; year-round availability is limited for poor families.

Tropical India should have abundant vitamin A sources—mango in summer is rich in carotenoids (12 mg per 100g raw), papaya year-round (263 μg retinol equivalent per 100g). Yet deficiency persists because poverty limits access and seasonal variation creates gaps in winter months.

3RDA and Bioavailability

RDA is 700 μg RAE (retinol activity equivalent) for women, 900 μg for men. But bioavailability of plant carotenoids is low—conversion to retinol is inefficient, and absorption depends on dietary fat and food matrix. Eating raw carrot with no fat yields <10% absorption; eating cooked carrot with ghee yields ~25–30%. For vegetarian populations relying on carotenoids, effective intake is much lower than apparent intake. A vegetarian woman eating 2,000 μg of dietary carotenoids might achieve only 500–700 μg of active retinol equivalent—just at the RDA.

4Deficiency in India

Vitamin A deficiency affects ~2–5 million preschool children in India; half have clinical signs (corneal scarring, blindness). Among women of reproductive age, subclinical deficiency is common. Why? Poverty (vegetables unaffordable for ₹200/day families), seasonal gaps (winter without greens or mango), loss of vitamin A during cooking (fat-soluble vitamins are more stable than water-soluble ones, but oxidation and heating still destroy some), and malabsorption from repeated infections. Public-health programs in India distribute vitamin A capsules to children under 5 (annual supplementation); this has reduced deficiency, but the problem persists.

Next: Vitamin A comes from two sources: preformed retinol eaten directly, and carotenoids that your body must convert. The conversion efficiency varies by type of carotenoid and individual genetics, affecting how much retinol you actually obtain from plant foods.

◆ Lesson 2.3 Carotenoids and Vitamin A Conversion

Learning goal: Understand how carotenoids are converted to retinol, why conversion is inefficient, and how genetics and diet affect this process.

Plants make carotenoids—pigments that give them color and protect against oxidative stress. Your body takes some carotenoids and converts them to retinol. But not all carotenoids are converted equally. α-carotene and β-carotene are provitamin A (your body converts them); lycopene, lutein, and xanthophyll are not (you absorb them but do not convert them to retinol, though they have other benefits). Of those that convert, β-carotene is most abundant in plant foods but less efficiently converted than you might think. Genetics, diet, and individual variation make conversion unpredictable. Two people eating identical β-carotene may have different retinol status.

1Which Carotenoids Convert to Vitamin A?

Provitamin A carotenoids: β-carotene (most common), α-carotene, γ-carotene. Your small intestine contains carotenoid oxygenases (enzymes) that cleave these molecules into retinol or retinal. The cleavage step is regulated; your body makes retinol only if it is needed. Excess β-carotene is not converted; it accumulates in blood (causing carotenemia—yellowing of skin) but this is harmless and reversible by stopping intake.

Non-provitamin A carotenoids: Lycopene (tomato, guava, papaya, watermelon), lutein (leafy greens, corn), xanthophyll (corn, orange pumpkin, yellow maize). These are absorbed and beneficial for eye health and antioxidant function, but your body does not convert them to retinol. Eating only lycopene-rich foods (tomato-heavy diet) will not prevent vitamin A deficiency.

2Conversion Efficiency and the RAE

The conversion of β-carotene to retinol is inefficient. Historically, 1 μg of β-carotene was thought to equal 1/6 μg of retinol (β-carotene was 6 times less efficient). Newer research suggests 6–12:1 ratio (or worse) depending on food matrix, cooking, and individual genetics. To standardize, scientists use RAE (retinol activity equivalent): 1 μg RAE = 1 μg retinol = 12 μg β-carotene (from food) = 2 μg β-carotene (from supplement, which is more bioavailable). So when you see "700 μg RAE" RDA, that means 700 μg retinol OR 8,400 μg β-carotene from food.

3Factors Affecting Conversion

Genetic variation: A gene (BCO1) encodes the main carotenoid oxygenase. Genetic polymorphisms affect conversion efficiency—some people convert β-carotene efficiently (high-responders), others poorly (low-responders). A low-responder with a common SNP may have 50% lower conversion efficiency. This explains why two vegetarians eating identical β-carotene have different serum retinol.

Dietary fat: Conversion requires intestinal absorption; fat is necessary. Low-fat diets impair carotenoid absorption and conversion.

Food matrix: Carotenoids are fat-soluble and entrapped in plant cells. Cooked and pureed carrot (better bioavailability) yields more retinol than raw carrot (cell walls limit extraction). Oil-based cooking enhances absorption.

Other dietary factors: Zinc is needed for retinoid receptor synthesis; zinc deficiency impairs vitamin A utilization despite adequate intake. Similarly, protein is needed; severe malnutrition impairs conversion.

4Implications for Indian Diets

India's vegetarian populations rely on carotenoid conversion. Yet this conversion is inefficient and variable. A vegetarian woman eating dark greens, sweet potato, and mango may achieve the RDA. But a low-responder with genetic variation might not. Fortified foods (flour, oil fortified with retinol) and periodic supplementation (as in public-health programs) ensure all populations are covered. This is why nutrition programs in India target vegetarian and vegan populations for vitamin A screening and supplementation—not because vegetables are inadequate, but because conversion is unpredictable.

Next: Vitamin D is unique among vitamins—your body synthesizes it on skin in sunlight, but intake is essential in winter or when sun exposure is limited. We examine vitamin D metabolism, sources, and the epidemic of deficiency in India.

◆ Lesson 2.4 Vitamin D

Learning goal: Understand vitamin D's sources, synthesis on skin, dietary sources in India, and why deficiency is endemic despite year-round sunshine.

Vitamin D is unique: your body manufactures it. Expose skin to midday sun (UVB radiation), and your liver and kidneys convert 7-dehydrocholesterol to calcidiol (25-OH vitamin D) to calcitriol (1,25-OH vitamin D)—the active hormone form. Yet vitamin D deficiency is endemic in India—a tropical country with abundant sunshine. Why? Skin pigmentation, indoor work, cultural clothing (covering skin), pollution that blocks UVB, and low dietary intake all conspire. Vitamin D deficiency affects bone health, immunity, muscle function, and possibly chronic disease risk. Understanding deficiency in the Indian context is essential for any nutrition professional.

1Sources of Vitamin D

Sunlight (UVB radiation): The primary source for humans. Midday sun at latitudes near the equator (including most of India) provides sufficient UVB for vitamin D synthesis. 15–30 minutes of midday sun exposure (arms, legs, face exposed) produces ~10,000–25,000 IU of vitamin D, depending on skin tone, sunscreen use, and season. Darker skin pigmentation (melanin) reduces UVB penetration; a dark-skinned person needs 3–6 times longer sun exposure than a fair-skinned person to synthesize the same amount of vitamin D. This is one reason vitamin D deficiency is more prevalent among dark-skinned populations in high latitudes, but also in India among those with high melanin and low sun exposure.

Dietary sources: Fish (salmon, mackerel, sardines provide 400–1,000 IU per 100g), egg yolk (40–50 IU per yolk), fortified milk (200–300 IU per cup, rare in India except urban areas), mushrooms (100–500 IU per 100g if exposed to sunlight), fortified foods. Most Indian diets are low in vitamin D from food; people rely on synthesis.

2Why Deficiency Occurs in India

Inadequate sun exposure: Despite tropical location, many Indians have limited outdoor time. Urban populations work indoors; rural populations may work indoors during peak sun hours (agricultural work often happens early morning or late afternoon). Children in cities attend school indoors, play indoors, and are driven (not walked) to school. Elderly populations are housebound.

Skin pigmentation: Melanin protects against UV damage but reduces vitamin D synthesis. Dark-skinned populations in the same location as fair-skinned populations synthesize less vitamin D per unit sun exposure. In Northern India (lower solar angle in winter), deficiency is especially prevalent among dark-skinned populations.

Cultural factors: Hijab, niqab, and other traditional clothing that covers skin reduces synthesis. Sunscreen use (beneficial for skin cancer prevention) reduces synthesis. Dust and air pollution in Indian cities blocks some UVB radiation.

Dietary intake: Most Indian diets are low in fish, eggs, and fortified dairy. Vegetarian and vegan diets contain almost no vitamin D. Only fortified foods or supplements provide reliable dietary intake.

Malabsorption: Celiac disease, Crohn's, and cystic fibrosis impair fat absorption, reducing vitamin D absorption even when intake is adequate.

3Seasonal Variation in India

India's tropical latitude means relatively constant solar angle year-round, but winter sunlight (December–January in North India) has lower intensity. The sun must be >45° above the horizon for UVB to penetrate the atmosphere; in winter, this window is shorter, and synthesis drops. Northern India (Delhi, Punjab) has pronounced seasonal variation; Southern India (Bangalore, Chennai) has less. But even in the South, winter synthesis is reduced, and for populations with high melanin or low sun exposure, winter deficiency is common.

Next: Vitamin D is absorbed and stored as calcidiol (25-OH vitamin D), then converted to the active hormone calcitriol (1,25-OH vitamin D) in kidneys. Understanding this metabolism reveals how kidney and liver disease affect vitamin D status, and why testing calcidiol is the standard.

◆ Lesson 2.5 Vitamin D Metabolism

Learning goal: Trace vitamin D's path from skin synthesis or dietary intake to active hormone form, and understand how kidneys regulate this process.

Vitamin D's journey is complex: it starts as 7-dehydrocholesterol on skin (converted to cholecalciferol by UVB), or as cholecalciferol from food. In the liver, it is hydroxylated to calcidiol (25-OH vitamin D)—the storage form measured in blood tests. In the kidney, calcidiol is hydroxylated to calcitriol (1,25-OH vitamin D)—the active hormone. The kidney tightly regulates this final step, increasing conversion when calcium is low or phosphorus is high, and suppressing it when calcium is replete. This sophisticated system means vitamin D status is maintained until stores are severely depleted—but it also means kidney disease disrupts vitamin D metabolism catastrophically.

1Step 1: Synthesis and Dietary Intake

Cholecalciferol (vitamin D3) is synthesized on skin from 7-dehydrocholesterol when exposed to UVB. It is also obtained from food (fish, fortified milk). Ergocalciferol (vitamin D2) comes from fungal sources (mushrooms, some fortified foods). Both D2 and D3 are transported to the liver, bound to vitamin D-binding protein (DBP) in blood.

2Step 2: Liver Hydroxylation (25-hydroxylation)

The liver enzyme 25-hydroxylase (CYP2R1) adds a hydroxyl group to cholecalciferol or ergocalciferol, producing calcidiol (25-OH vitamin D). This is the major circulating form and the one measured on blood tests. Calcidiol is then stored in adipose tissue and bone. Serum calcidiol reflects vitamin D stores accumulated over months; a single day of sun exposure does not change blood calcidiol, but consistent sun exposure over weeks raises it.

3Step 3: Kidney Hydroxylation (1-alpha-hydroxylation)

The kidney enzyme 1-alpha-hydroxylase (CYP27B1) adds another hydroxyl group to calcidiol, producing calcitriol (1,25-OH vitamin D)—the most biologically active form. Calcitriol acts as a hormone, binding to vitamin D receptors (VDRs) on cells throughout the body. It is tightly regulated: when serum calcium is low or PTH is high, kidney production of calcitriol increases; when calcium is replete or FGF23 is elevated (a phosphate-regulating hormone), production decreases. The kidney converts only what is needed, not a fixed amount.

4Functions of Active Vitamin D (Calcitriol)

Calcium regulation: Calcitriol increases intestinal calcium absorption and renal calcium reabsorption, raising serum calcium. In deficiency, PTH remains elevated, leading to secondary hyperparathyroidism and bone loss.

Phosphate regulation: Calcitriol increases intestinal phosphate absorption and regulates renal excretion via FGF23.

Immunity: Calcitriol activates macrophages and dendritic cells, enhancing innate immunity. Deficiency impairs immune response to infection and vaccination.

Bone mineralization: Calcitriol is essential for osteoblast differentiation and bone formation. Without it, rickets (children) or osteomalacia (adults) develops.

Cell differentiation: Calcitriol regulates hundreds of genes involved in cell growth, differentiation, and apoptosis.

5Kidney Disease and Vitamin D Metabolism

In chronic kidney disease (CKD), kidney function declines, reducing both calcidiol synthesis and calcitriol synthesis. Serum calcidiol drops, calcium falls, PTH rises, and secondary hyperparathyroidism develops—leading to bone loss even if dietary calcium is adequate. Additionally, FGF23 rises (in response to phosphate retention), further suppressing 1-alpha-hydroxylase. Vitamin D supplementation (calcidiol or calcitriol) is medically necessary in CKD; standard cholecalciferol supplements do not bypass the kidney block.

Next: Vitamin E is a potent antioxidant distributed in all cell membranes. Unlike vitamins A and D, deficiency is rare and toxicity is uncommon, but its role in protecting cells from oxidative damage is essential.

◆ Lesson 2.6 Vitamin E

Learning goal: Understand vitamin E's structure, antioxidant function, food sources, and why deficiency is rare in humans but important in specific disease states.

Vitamin E is actually a family of eight related molecules: four tocopherols (alpha, beta, gamma, delta) and four tocotrienols. Alpha-tocopherol is the most biologically active and the form maintained in blood. Vitamin E embeds itself in cell membranes (where fatty acids are) and acts as an antioxidant—scavenging reactive oxygen species and protecting polyunsaturated fat from oxidative damage. It works synergistically with vitamin C (which regenerates oxidized vitamin E) and selenium (which is part of glutathione peroxidase, another antioxidant enzyme). Despite its important role, vitamin E deficiency is rare in humans eating a normal diet because plant oils are rich sources and storage is extensive. However, the supplement industry promotes high-dose vitamin E, and some populations (premature infants, people with severe fat malabsorption) do need it.

1Sources of Vitamin E

Plant oils: Sunflower oil (41 mg/100ml), safflower oil (35 mg/100ml), wheat germ oil (149 mg/100ml). These are the most concentrated sources, though consumption is limited in quantity.

Nuts and seeds: Almonds (26 mg/100g), sunflower seeds (36 mg/100g), peanuts (8 mg/100g). Modest amounts in typical serving sizes but contribute to intake.

Whole grains: Wheat germ is rich (15 mg/100g); whole-grain wheat and oats contain some, but refining removes most.

Leafy greens: Spinach, kale, broccoli (modest amounts, 1–2 mg per 100g cooked).

In India: Peanut (groundnut) is widely available and affordable; mustard oil and coconut oil have some vitamin E. Most Indian diets contain ~8–12 mg of vitamin E daily, meeting or approaching the RDA (15 mg). Deficiency is not common except in malabsorption.

2Antioxidant Function

Vitamin E is a chain-breaking antioxidant. When a free radical attacks a polyunsaturated fatty acid in a cell membrane, it initiates a chain reaction of oxidation. Vitamin E steps in, donates an electron to the free radical, stops the chain, and becomes oxidized itself (tocopheroxyl radical). Vitamin C then regenerates vitamin E, restoring its antioxidant capacity. This is synergy: neither vitamin alone is as effective as both working together. The result is protection of cell membranes and reduction of oxidative damage—relevant to aging, atherosclerosis, and neurodegeneration. However, clinical trials of high-dose vitamin E supplementation have mostly shown no benefit for cardiovascular disease or cancer in well-nourished populations, suggesting that antioxidant defense is complex and "more is not better."

3Deficiency (Rare)

Vitamin E deficiency occurs mainly in: (1) premature infants (immature fat absorption, high oxygen exposure in neonatal care), (2) fat malabsorption (celiac, Crohn's, cystic fibrosis, post-bariatric surgery), (3) genetic abetalipoproteinemia (no apolipoprotein B, cannot transport vitamin E). Clinical signs are neurological: peripheral neuropathy, ataxia, loss of vibration sense, cognitive decline. These are irreversible if deficiency is prolonged. At-risk populations benefit from monitoring and supplementation; the general population does not.

4Toxicity

Vitamin E toxicity is rare from food (no UL set specifically for food, only for supplements). Supplemental doses above 1,000 IU daily (roughly 670 mg) may increase bleeding risk (vitamin E inhibits platelet aggregation), especially in people taking anticoagulants (warfarin) or antiplatelet drugs (aspirin). Some studies suggest high-dose vitamin E supplementation may increase mortality slightly in older populations, though evidence is weak and contested. The consensus: supplement vitamin E only if at-risk for deficiency (malabsorption, premature infant) or under medical supervision. Food sources are safe and adequate for the general population.

Next: Vitamin K is essential for blood clotting and bone mineralization. It is synthesized by gut bacteria, reducing dietary dependence, but deficiency can occur in antibiotics use, malabsorption, or certain disease states.

◆ Lesson 2.7 Vitamin K

Learning goal: Understand vitamin K's functions in coagulation and bone, its sources, and why deficiency is rare in adults but can occur in newborns and certain disease states.

Vitamin K is a cofactor for a specific carboxylase enzyme that adds carboxyl groups to glutamic acid residues in prothrombin, factors VII, IX, and X (the vitamin K-dependent clotting factors), and osteocalcin (a bone protein). This single enzymatic step is essential for coagulation and bone mineralization. Vitamin K deficiency leads to bleeding (because clotting factors are inactive) and poor bone mineralization. Yet deficiency is rare in adults because gut bacteria synthesize vitamin K2 (menaquinones), supplementing dietary intake. Newborns lack this bacterial flora and receive vitamin K injections to prevent hemorrhagic disease. Certain populations—people taking broad-spectrum antibiotics, those with severe dysbiosis, people with malabsorption—are at risk. Anticoagulant medications (warfarin) work by inhibiting vitamin K's function, not by depleting it.

1Two Forms: K1 and K2

Vitamin K1 (phylloquinone): Dietary form from plants (leafy greens, cruciferous vegetables, some oils). Absorbed in small intestine, transported to liver, and used for synthesis of clotting factors. More readily available from food.

Vitamin K2 (menaquinones): Synthesized by gut bacteria (Bacteroides, E. coli) and to some extent by human cells. Also obtained from some fermented foods (natto—fermented soybeans, contains MK-7; some cheeses contain MK-8, MK-9). K2 is absorbed throughout the colon and accumulates in bone and vascular tissue more efficiently than K1.

2Functions

Blood coagulation: Vitamin K-dependent carboxylase activates prothrombin and factors VII, IX, X. These are essential for the coagulation cascade; deficiency prolongs PT/INR and increases bleeding risk.

Bone mineralization: Vitamin K carboxylates osteocalcin, an osteoblast-secreted protein that binds calcium and is incorporated into bone matrix. Deficiency impairs bone mineralization and may increase fracture risk. Some studies (though not all) suggest adequate vitamin K reduces fracture risk, especially in women.

Vascular function: Matrix Gla protein (MGP), another vitamin K-dependent protein, accumulates in arteries and regulates vascular calcification. Deficiency is hypothesized to increase arterial calcification, though clinical evidence is mixed.

3Deficiency (Rare in Adults)

Hemorrhagic disease of the newborn: Newborns have sterile guts (no bacteria) and low placental transfer of vitamin K; they are at risk of spontaneous bleeding (intracranial, GI) in the first days/weeks of life. IM or oral vitamin K (phylloquinone) at birth prevents this.

Antibiotic-induced deficiency: Broad-spectrum antibiotics kill gut bacteria; vitamin K synthesis drops. Patients on prolonged antibiotics may have prolonged PT and bleeding risk, especially if dietary intake is also low.

Malabsorption: Celiac disease, Crohn's, pancreatic insufficiency reduce vitamin K1 absorption and synthesis of K2.

Severe malnutrition: Rare in developed countries, but seen in famine, severe chronic disease, or extreme restrictive dieting.

4Vitamin K and Anticoagulants

Warfarin (Coumadin), an anticoagulant, works by inhibiting vitamin K-dependent carboxylation. It does not deplete vitamin K; it blocks its function. Patients on warfarin must maintain stable dietary vitamin K intake (leafy greens provide consistent K1) because fluctuating intake affects INR (International Normalized Ratio). Avoiding vitamin K-rich foods while on warfarin is unnecessary and outdated; consistency is what matters. Sudden increases in dietary K1 raise INR (less anticoagulation); sudden decreases lower INR (more anticoagulation). Regular monitoring and dose adjustment compensate for dietary changes.

Next: All four fat-soluble vitamins require dietary fat for absorption. Understanding absorption mechanisms and the factors that optimize or impair it explains bioavailability and guides practical recommendations.

◆ Lesson 2.8 Absorption of Fat-Soluble Vitamins

Learning goal: Describe the intestinal absorption mechanism for fat-soluble vitamins and identify factors that enhance or inhibit absorption.

Fat-soluble vitamins do not dissolve in the aqueous environment of the intestine or blood. They must be incorporated into lipid particles (chylomicrons) for absorption and transport. This process requires several components: dietary fat (minimum ~5–10 g per meal enhances absorption), intact intestinal epithelium, pancreatic lipase (to emulsify and digest fat), and bile acids (to form micelles containing the fat-soluble vitamins). If any step fails—if you eat no fat, if you have pancreatic insufficiency, if bile flow is blocked, if you have intestinal disease—fat-soluble vitamin absorption plummets. This is why people with celiac disease, Crohn's, cystic fibrosis, and biliary obstruction are at risk for deficiency of all four.

1The Absorption Process

Step 1: Emulsification and micelle formation. Bile acids from the gallbladder emulsify dietary fat, breaking it into smaller droplets. Pancreatic lipase breaks triglycerides into fatty acids and monoglycerides. Together with bile acids, these form micelles—tiny spheres with a lipid core and bile acid shell. Fat-soluble vitamins (A, D, E, K) incorporate into the lipid core of micelles.

Step 2: Transport to epithelial cells. Micelles travel to the intestinal epithelium and deliver their contents to enterocytes (intestinal cells). Specific transporters (SR-BI, CD36, NPC1L1) on enterocytes facilitate uptake of vitamins and other lipids.

Step 3: Packaging into chylomicrons. Inside enterocytes, fat-soluble vitamins are packaged with other lipids into chylomicrons—large lipoprotein particles. Chylomicrons are secreted into lymphatic vessels (lacteals) and eventually reach blood via the thoracic duct. This is why fat-soluble vitamin absorption bypasses the portal blood initially; they travel via lymph, not directly to the liver.

Step 4: Transport and storage. In blood, chylomicrons deliver fat-soluble vitamins to tissues. The liver takes up chylomicron remnants and repackages vitamins for storage or re-secretion in VLDL (very-low-density lipoprotein).

2Factors That Enhance Absorption

Dietary fat: At least 5–10 g of fat per meal optimizes absorption. Oils (olive, coconut, ghee), nuts, seeds, and animal products provide this. Low-fat meals impair absorption significantly.

Food matrix: Cooked and processed foods often have better bioavailability than raw (cell walls are disrupted, vitamins more accessible). Fat-soluble vitamins in pureed or minced vegetables are more bioavailable than in whole form.

Stomach acid and pancreatic function: Normal acid and pancreatic lipase are needed for micelle formation. Achlorhydria (no stomach acid) or pancreatic insufficiency reduces absorption.

Bile acid synthesis: A functioning liver synthesizes bile acids; gallstones, bile duct obstruction, or hepatic disease reduce bile availability.

3Factors That Inhibit Absorption

Low dietary fat: Fat-free meals result in minimal micelle formation. A person eating rice with vegetables but no oil or ghee has poor fat-soluble vitamin absorption.

Intestinal disease: Celiac disease (villous atrophy), Crohn's (inflammation, strictures), short-bowel syndrome (reduced absorptive surface) all reduce absorption surface and function.

Pancreatic insufficiency: Chronic pancreatitis or cystic fibrosis reduces lipase; fat digestion and absorption fail.

Biliary obstruction: Gallstones, pancreatic cancer, or hepatic cirrhosis block bile flow; micelle formation fails.

Certain medications: Orlistat (weight-loss drug that inhibits lipase) reduces fat digestion; cholestyramine (binds bile acids) reduces micelle formation.

Next: When absorption fails—whether from malabsorption, restricted diets, or deficient intake—the spectrum of deficiency patterns emerges. We examine the clinical signs and biochemical markers that indicate inadequate status in each fat-soluble vitamin.

◆ Lesson 2.9 Deficiency Patterns

Learning goal: Recognize the progressive stages and clinical signs of deficiency for each fat-soluble vitamin, and understand which populations are at highest risk.

Each fat-soluble vitamin has a distinct deficiency signature. Vitamin A deficiency causes night blindness, then conjunctival xerosis, then corneal scarring and blindness. Vitamin D deficiency causes rickets in children, osteomalacia in adults, and secondary hyperparathyroidism. Vitamin E deficiency causes neurological damage (neuropathy, ataxia). Vitamin K deficiency causes bleeding and poor bone health. Understanding these distinct patterns allows early detection and intervention. Deficiency is rare in developed countries (except in malabsorption), but common in developing regions and in specific disease states. India, despite abundant sources, has endemic deficiency of vitamins A and D due to poverty and limited access.

1Vitamin A Deficiency Stages

Night blindness: Earliest sign. Rod cells in the retina have depleted rhodopsin. Child or adult cannot see in dim light; stumbles in dusk, sits close to lamp. Reversible with vitamin A supplementation.

Xerophthalmia: Conjunctival xerosis (drying), Bitot spots (foamy triangular patches on conjunctiva), corneal xerosis, and eventual corneal scarring. Corneal damage is irreversible; vision loss is permanent if untreated.

Systemic effects: Impaired immunity (increased infection, slower recovery), poor wound healing, squamous metaplasia of respiratory and GI epithelium (increased infection risk).

2Vitamin D Deficiency Stages

Biochemical insufficiency: Serum calcidiol 20–29 ng/mL (50–74 nmol/L). PTH begins to rise (secondary hyperparathyroidism). No clinical signs yet. This is the stage where intervention (sun exposure or supplementation) prevents progression.

Rickets (children): Bone does not mineralize. Skeletal deformities: bowing of legs, frontal bossing, rachitic rosary (enlarged costochondral junctions), delayed tooth eruption, delayed motor milestones. Growth is stunted.

Osteomalacia (adults): Bone pain, muscle weakness, fatigue. Serum calcium drops, phosphate drops, PTH rises. Fractures from minor trauma. Muscle pain is often misdiagnosed as fibromyalgia or depression.

Secondary hyperparathyroidism: Sustained elevation of PTH (from low calcidiol) leads to increased bone turnover, loss of cortical bone, and fracture risk even if calcium is normalized.

3Vitamin E Deficiency (Rare)

Neurological signs: Peripheral neuropathy (distal weakness and sensory loss), ataxia (loss of coordination), loss of vibration sense, cognitive decline. These are progressive and irreversible if deficiency is prolonged.

Risk groups: Premature infants (immature absorption), fat malabsorption (celiac, Crohn's, cystic fibrosis), abetalipoproteinemia (genetic inability to transport fat-soluble vitamins).

4Vitamin K Deficiency (Rare in Adults)

Bleeding: Prolonged PT/INR, easy bruising, bleeding gums, hematuria (blood in urine), GI bleeding, intracranial hemorrhage (especially in newborns). Onset is acute if severe (malabsorption on antibiotics) or gradual if mild (malnutrition).

Bone health: Impaired osteocalcin carboxylation may reduce bone mineralization and increase fracture risk, though clinical evidence is mixed.

Risk groups: Newborns (no gut bacteria), people on prolonged antibiotics with malabsorption, severe malnutrition, anticoagulation overdose, hepatic disease (impaired clotting factor synthesis).

Next: Understanding deficiency is half the story; the other half is understanding toxicity. Fat-soluble vitamins can accumulate to harmful levels, and it is important to recognize safe upper limits and avoid excessive supplementation.

◆ Lesson 2.10 Toxicity and Supplement Safety

Learning goal: Recognize the toxicity risks of fat-soluble vitamins, understand upper limits, and identify when supplementation is appropriate versus harmful.

Storage is the hallmark of fat-soluble vitamins; it is also their toxicity risk. Unlike water-soluble vitamins (where excess is excreted and toxicity is rare), fat-soluble vitamins accumulate in liver and adipose tissue. Chronic intake above the upper limit (UL) leads to storage and toxicity. Vitamin A toxicity causes bone loss, liver damage, and birth defects. Vitamin D toxicity causes hypercalcemia and kidney stone risk. Vitamin E toxicity is rare but may increase bleeding. Vitamin K toxicity is very rare. Supplementation with fat-soluble vitamins should target specific deficiency or risk; shotgun megadosing is risky, especially in pregnancy or in people with liver disease.

1Vitamin A Toxicity

Acute toxicity: Rare, occurs with extreme single doses (>300,000 IU). Presents with headache, nausea, vomiting, visual disturbances, skin peeling. Resolves when intake stops.

Chronic toxicity: From prolonged supplementation at 10,000–50,000 IU daily (or cumulative high intake). Manifests as bone loss (increased fracture risk, especially hip and spine), liver cirrhosis, hair loss, dry skin, CNS effects (headache, drowsiness, irritability), and birth defects (in pregnancy—teratogenic). The UL is 10,000 IU daily for adults; pregnant women should not exceed 10,000 IU (some recommend no more than 3,000 IU during pregnancy due to birth defect risk).

Risk groups: Excessive supplement users (esp. "health enthusiasts" taking mega doses), pregnancy, liver disease (impaired storage and excretion).

2Vitamin D Toxicity

Hypercalcemia: Calcitriol increases intestinal calcium absorption and renal reabsorption. Chronic high vitamin D raises serum calcium above 10.5 mg/dL (normal 8.5–10). Symptoms: thirst, polyuria (excessive urination), nausea, weakness, kidney stones, arterial calcification.

Mechanism: FGF23 rises (phosphate-regulating hormone); PTH suppression reduces. In the presence of chronic high vitamin D, calcium excretion cannot compensate, and hypercalcemia develops.

UL: 4,000 IU daily for adults (recently, some experts argue for higher ULs based on new evidence, but 4,000 IU remains official). Serum calcidiol >100 ng/mL (250 nmol/L) carries risk; >150 ng/mL indicates clear excess.

Risk groups: Supplement enthusiasts taking 10,000+ IU daily, granulomatous disease (produces calcitriol uncontrollably; vitamin D supplementation is contraindicated), hypersensitivity to vitamin D, kidney disease (impaired phosphate excretion worsens hypercalcemia).

3Vitamin E Toxicity

Bleeding risk: High-dose vitamin E (>1,000 IU daily, roughly 670 mg) inhibits platelet aggregation, increasing bleeding. Risk is especially high when combined with anticoagulants (warfarin) or antiplatelet agents (aspirin). Case reports of intracranial hemorrhage and GI bleeding in people taking excessive vitamin E.

Other effects: Some studies suggest high-dose supplementation may increase all-cause mortality slightly in older populations, though evidence is not conclusive. The mechanism is unclear (possibly oxidative stress from excessive antioxidants or interference with normal cellular signaling).

UL: 1,000 IU daily for supplements (no UL for food). Toxicity from food alone is essentially impossible.

4Vitamin K Toxicity

Extremely rare. Phylloquinone (K1) has no established toxicity even at very high doses; the body excretes excess. Menadione (synthetic vitamin K) and high-dose menaquinone (K2) may cause hemolytic anemia in infants with G6PD deficiency or increase bilirubin, but clinical toxicity in adults is not documented.

5When Supplementation Is Warranted

Vitamin A: Deficiency (low serum retinol, night blindness, xerophthalmia), pregnancy with risk of deficiency (vegetarian, poor diet), measles in deficient populations (supplementation reduces mortality).

Vitamin D: Insufficient or deficient status (serum calcidiol <30 ng/mL), malabsorption, dark skin in high latitudes, limited sun exposure, pregnancy, lactation, osteoporosis risk.

Vitamin E: Fat malabsorption (celiac, Crohn's, cystic fibrosis, post-bariatric surgery), abetalipoproteinemia.

Vitamin K: Hemorrhagic disease prevention in newborns, malabsorption, prolonged antibiotic use with bleeding risk.

Next: We have covered the four fat-soluble vitamins in detail. Now we consolidate key concepts, prepare for application, and assess readiness for advanced chapters on water-soluble vitamins and minerals.

◆ Lesson 2.11 Chapter Revision

Learning goal: Consolidate key concepts from Chapter 2 and assess mastery of fat-soluble vitamin science.

Fat-Soluble Vitamin Overview

What makes them "fat-soluble"? These four vitamins dissolve in fat but not water. They require dietary fat, bile acids, pancreatic lipase, and intact intestine for absorption. They are transported in lipoproteins (chylomicrons) and stored in liver and adipose tissue. Storage means toxicity is possible with chronic excess.

Vitamin A: Retinol (preformed from animal sources) and carotenoids (from plants, converted to retinol with 12:1+ inefficiency). Functions: vision (rhodopsin), immunity, epithelial cell differentiation, gene expression. Deficiency: night blindness, xerophthalmia, corneal scarring, impaired immunity. Toxicity: bone loss, liver damage, birth defects (teratogenic). UL = 10,000 IU. Indian sources: liver, dairy, eggs (animal); sweet potato, mango, papaya, greens (plant).

Vitamin D: Synthesized on skin (UVB) and obtained from diet. Metabolism: skin/diet → liver (calcidiol storage form, measured in blood) → kidney (calcitriol active hormone, tightly regulated). Functions: calcium regulation, immunity, bone mineralization, gene expression. Deficiency: rickets (children), osteomalacia (adults), secondary hyperparathyroidism, immune dysfunction. Toxicity: hypercalcemia, kidney stones, arterial calcification. UL = 4,000 IU. Endemic deficiency in India despite sunshine (low sun exposure, dark skin, poor diet). Testing: serum calcidiol (25-OH vitamin D) is the standard.

Vitamin E: Family of tocopherols and tocotrienols (alpha-tocopherol most active). Function: chain-breaking antioxidant in cell membranes, works with vitamin C and selenium. Deficiency: rare except in malabsorption or genetic disorders; causes irreversible neurological damage (neuropathy, ataxia). Toxicity: rare but possible (bleeding risk at >1,000 IU daily). UL = 1,000 IU (supplements). Sources: plant oils, nuts, seeds, whole grains. Indian foods: peanut (groundnut), oils.

Vitamin K: K1 (phylloquinone from plants) and K2 (menaquinones from bacteria and fermented foods). Functions: carboxylation of clotting factors (prothrombin, VII, IX, X) and bone protein (osteocalcin). Deficiency: rare in adults (gut bacteria synthesize K2) but common in newborns (sterile guts), people on antibiotics (bacteria killed), malabsorption, liver disease. Signs: bleeding, prolonged PT. Toxicity: essentially non-existent. Warfarin interaction: warfarin blocks vitamin K function (not depletion); dietary consistency matters, not avoidance.

Absorption requirements: Dietary fat (≥5–10 g/meal), intact intestine, pancreatic lipase, bile acids. Any failure (fat malabsorption, pancreatic disease, biliary obstruction, intestinal disease) increases deficiency risk for all four simultaneously.

Deficiency in India: Vitamin A deficiency affects millions of preschool children and women (poor access to diverse foods, low bioavailability of carotenoids in vegetarian diets, cooking losses). Vitamin D deficiency is endemic (low sun exposure in urban/indoor workers, dark skin reducing synthesis, poor dietary intake). Vitamin E and K deficiencies are rare except in malabsorption. Public-health interventions: vitamin A and D supplementation programs for high-risk groups, food fortification (oils, flour, salt), and nutrition education on food combinations enhancing absorption (vitamin C + iron, fat + fat-soluble vitamins).

Clinical Application

When a patient presents with fatigue, bone pain, poor wound healing, or immune dysfunction, fat-soluble vitamin deficiency should be considered, especially if risk factors exist (malabsorption, restricted diet, limited sun exposure, low dietary fat intake). A comprehensive assessment includes dietary history, clinical signs, and blood tests (serum retinol, calcidiol, possibly tocopherol, PT/INR for vitamin K). Supplementation should target deficiency, not optimize in well-nourished people (risk > benefit). Special populations—pregnant women, vegans, people with malabsorption, premature infants—warrant proactive assessment and targeted supplementation.

◆ Lesson 2.12 Clinical Case Studies

Learning goal: Apply Chapter 2 concepts to real-world scenarios involving fat-soluble vitamin deficiency and toxicity.

Case Study 1: The Malabsorbing Child

Aarav, 4 years old, has been failing to thrive for 2 years. His mother reports chronic diarrhea (especially after fatty foods), abdominal bloating, and poor growth. Developmental milestones are delayed. Physical exam: wasted appearance, pale conjunctiva, poor muscle mass. History: born premature, had necrotizing enterocolitis (bowel inflammation) in NICU; recovered but has residual intestinal dysfunction (suspected short-bowel syndrome or chronic malabsorption).

Blood tests: Hemoglobin 9.5 g/dL (anemia—likely iron deficiency), serum retinol 12 μg/dL (deficient, <20), serum calcidiol 12 ng/mL (severely deficient, <20), PT 14 seconds (slightly prolonged, normal <13), prealbumin 15 mg/dL (low, indicating protein malnutrition).

Analysis: Aarav has malabsorption affecting all fat-soluble vitamins (A, D, E, K) and protein, iron. Intestinal damage (residual from necrotizing enterocolitis or ongoing disease) impairs fat absorption. Symptoms: chronic diarrhea (malabsorption, lactose intolerance), growth failure (protein-energy malnutrition), pale conjunctiva (anemia + vitamin A deficiency). Night blindness (vitamin A deficiency) may be present but hard to assess in a 4-year-old. Rickets (vitamin D deficiency) may be developing (early wrist/ankle swelling, poor growth). Bleeding risk (vitamin K deficiency) is present (PT is prolonged).

Management:

1. Diagnosis: Confirm malabsorption: fecal fat test (>7 g/24h suggests steatorrhea—fat malabsorption); consider endoscopy/biopsy if underlying cause unclear.
2. Nutritional rehabilitation: Assess current diet; may need specialized high-calorie, easily absorbed formula if oral intake is inadequate.
3. Fat-soluble vitamin supplementation: All four are needed—vitamin A (10,000 IU 3×/week), vitamin D (2,000 IU daily + oral calcium supplement), vitamin E (water-dispersible form, 50 IU daily, absorbed better than oil-based form), vitamin K (phylloquinone 1 mg daily or IM 1 mg monthly).
4. Iron supplementation: Ferrous sulfate 5 mg/kg/day (or iron-fortified formula if relying on formula feeding).
5. Address underlying cause: If inflammatory bowel disease (Crohn's), optimize disease management. If short-bowel, optimize remaining bowel function (probiotics, appropriate food texture). If lactose intolerance, switch to lactose-free formula/milk.
6. Reassess in 8–12 weeks: Repeat blood tests (retinol, calcidiol, hemoglobin, PT, prealbumin). Measure growth (height, weight velocity). Adjust supplementation based on response.

Outcome: After 3 months of supplementation and formula adjustment, Aarav's hemoglobin rises to 11, retinol to 30, calcidiol to 25 (still low but improving), PT normalizes. Growth velocity improves from 2 cm/year to 6 cm/year. By 6 months, most labs normalize; PT may take longer if vitamin K malabsorption persists, requiring IM dosing instead of oral.

Case Study 2: The Supplement Enthusiast

Priya, 45 years old, takes multiple supplements daily for "anti-aging and optimal health." Her regimen: vitamin A (50,000 IU), vitamin D (10,000 IU), vitamin E (1,200 IU), vitamin K (200 μg), plus multivitamin, fish oil, and CoQ10. She has no diagnosed deficiency, feels fine, and reads health blogs endorsing high-dose vitamins. Her doctor is concerned and orders blood tests.

Blood results: Serum retinol 120 μg/dL (high, >100 is concerning), calcidiol 68 ng/mL (high, >60 is concerning), PTH 32 pg/mL (elevated, normal 15–65; high-normal suggests subclinical hyperparathyroidism). Bone mineral density (DEXA) shows T-score –1.2 at spine, –0.8 at hip (low-normal but trending toward osteopenia). Liver function tests normal. Kidney function normal.

Analysis: Priya is accumulating fat-soluble vitamins. She is taking 5–10× the RDA for vitamins A and D. Serum retinol is elevated (>100 μg/dL is concerning for chronic toxicity); her calcium level is 10.2 mg/dL (high-normal, consistent with vitamin D excess driving absorption). PTH is trying to suppress (via calcitriol feedback), but PTH remains elevated—a sign that systemic calcium is trying to rise. Bone DEXA shows early bone loss, consistent with chronic vitamin A toxicity (increases bone turnover). No symptomatic hypercalcemia yet, but the trajectory is concerning.

Risks: Continued supplementation at this dose will likely lead to clinical hypercalcemia (thirst, polyuria, kidney stones), progressive bone loss, and possible liver dysfunction (though current liver tests are normal). Vitamin A toxicity may cause skin problems, hair loss, or joint pain (not yet present, but possible). She is at risk for kidney stones within 1–2 years if supplementation continues.

Counseling:

1. Stop high-dose supplementation. Switch to RDA doses (or less): vitamin A ≤3,000 IU (safer in reproductive-age women), vitamin D 800–1,000 IU, vitamin E 15 mg (from food), vitamin K from food or low-dose supplement if needed.
2. Educate on toxicity. Explain that vitamins are nutrients at appropriate doses and toxins at excess doses. No benefit is proven for megadosing in well-nourished people; risk is documented.
3. Monitor labs. Recheck serum retinol and calcidiol in 3 months after stopping high-dose supplements. PTH should normalize. Repeat DEXA in 1–2 years to assess bone recovery (vitamin A toxicity is partially reversible if supplementation stops early).
4. Encourage food-based approach. Focus on balanced diet (colorful vegetables for carotenoids, sun exposure for vitamin D, nuts/seeds for vitamin E, greens for vitamin K). Food provides vitamins without toxicity risk.

Outcome: After 3 months of stopping high-dose supplements and eating a balanced diet, serum retinol drops to 65 μg/dL (high-normal), calcidiol drops to 40 ng/mL (optimal), PTH normalizes to 35 pg/mL. By 1 year, DEXA shows slight improvement in bone density (early toxicity was reversible). Priya learns that "more is not better" and switches to food-based nutrition with appropriate supplementation only for documented deficiency.

Case Study 3: The Housebound Elderly Woman

Anjali, 72 years old, lives alone in a flat in Delhi. She is mostly housebound due to arthritis and fear of falling. Her diet is simple: rice, dal, occasionally cooked vegetables, milk with tea. She uses sunscreen on her face when she goes to the market (once weekly). She was recently diagnosed with osteoporosis (T-score –2.5 at spine) and has had two falls with fractures (wrist, ankle) in the past year.

Blood tests: Serum calcidiol 15 ng/mL (severely deficient), calcium 8.2 mg/dL (low-normal), phosphate 3.2 mg/dL (low-normal), PTH 78 pg/mL (elevated, indicating secondary hyperparathyroidism), alkaline phosphatase 65 IU/L (high-normal, indicating increased bone turnover).

Analysis: Anjali has severe vitamin D deficiency caused by: (1) limited sun exposure (housebound), (2) dark skin (melanin reduces UVB penetration), (3) low dietary vitamin D (milk in India is rarely fortified, no fish in her diet). Secondary hyperparathyroidism is present (elevated PTH). Her osteoporosis is likely multifactorial (age, estrogen deficiency postmenopausal, vitamin D deficiency, possible calcium inadequacy). Fracture risk is high; each fall increases mortality in elderly.

Management:

1. Vitamin D supplementation: 2,000 IU daily (or 50,000 IU weekly for 8 weeks, then monthly for maintenance). This is essential; she cannot synthesize adequate vitamin D from her current sun exposure.
2. Calcium supplementation: 1,000 mg daily (divided: 500 mg at breakfast, 500 mg at dinner) with vitamin D (vitamin D enhances absorption). Test for vitamin K status and supplement if needed (vitamin K supports osteocalcin carboxylation for bone mineralization).
3. Dietary counseling: Encourage: (a) increased milk intake (if tolerated); (b) fortified foods (fortified flour or oil, if available); (c) outdoor time (even 15 min daily at a window counts, though skin exposure is better); (d) calcium-rich foods (small fish with bones, leafy greens if available); (e) dietary vitamin K (leafy greens support both vitamin K and bone health).
4. Fall prevention: Physical therapy, home safety assessment (remove tripping hazards), assistive devices (cane, walker). Preventing fractures is as important as treating vitamin D deficiency.
5. Recheck labs in 3 months: Serum calcidiol should rise toward 30–50 ng/mL. PTH should fall as calcium is corrected. Repeat DEXA in 1–2 years to assess bone response to treatment.

Outcome: After 3 months of vitamin D and calcium supplementation plus increased sun exposure (daughter encourages her to sit by window daily), serum calcidiol rises to 32 ng/mL (sufficient), PTH drops to 45 pg/mL (closer to normal), calcium rises to 8.7 mg/dL (improved). She reports less bone pain. No new fractures in 6 months. By 1 year, DEXA shows stabilization of bone loss (not yet reversal, but arrest of decline). Fall risk remains high due to age and arthritis, but vitamin D repletion has reduced fracture severity and improved mobility slightly (muscle strength improves with vitamin D).

Mastery Scenarios

Scenario 1: A 28-year-old vegan woman with no apparent malabsorption eats a diverse diet (nuts, seeds, fortified plant milk, greens). Blood tests show serum retinol 50 μg/dL (low-normal), calcidiol 22 ng/mL (insufficient), vitamin E normal. What is her micronutrient status, and would supplementation help?

Scenario 2: A man with cirrhosis has low serum retinol, elevated INR, and low calcidiol. His doctor recommends vitamin A and D supplementation. What are the concerns? Is supplementation appropriate, or should it be contraindicated in cirrhosis?

Scenario 3: A pregnant woman in her second trimester asks about prenatal supplementation. Current supplements: prenatal vitamin (includes 3,500 IU vitamin A, 600 IU vitamin D), plus separate vitamin D supplement (4,000 IU daily), plus fish oil. Is her total vitamin A and D safe for pregnancy?